Steven Halper
Stock Analyst at Cantor Fitzgerald
(3.15)
# 1,004
Out of 4,818 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $6.03 | +82.42% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $5.10 | +488.24% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $3.90 | +310.26% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $7.71 | +3,791.05% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $86.08 | -1.25% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $30.69 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $147.60 | +241.46% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $10.47 | +3,624.93% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $8.98 | -10.91% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $7.07 | +1,950.92% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $5.95 | +3,009.24% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $336.69 | -24.26% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $263.61 | +51.74% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $24.18 | +32.37% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $62.12 | +32.81% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $6.03
Upside: +82.42%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $5.10
Upside: +488.24%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $3.90
Upside: +310.26%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $7.71
Upside: +3,791.05%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $86.08
Upside: -1.25%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $30.69
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $147.60
Upside: +241.46%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $10.47
Upside: +3,624.93%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $8.98
Upside: -10.91%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $7.07
Upside: +1,950.92%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $5.95
Upside: +3,009.24%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $336.69
Upside: -24.26%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $263.61
Upside: +51.74%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $24.18
Upside: +32.37%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $62.12
Upside: +32.81%